The ongoing Nrf2 signaling pathway is leading worldwide efforts to develop highly targeted therapeutic agents to control inflammatory symptoms and prevent and treat major diseases such as cancer and neurodegenerative diseases. The gene discussed is NFE2L2; the disease is neurodegenerative disease.